Acquisition Announced

Tarsus Pharmaceuticals acquisition of Alkeus Pharmaceuticals

US$450m consideration

Announced 6 Aug 2026

Advisers

Alkeus Pharmaceuticals

Target

Financial adviser
Legal adviser

Tarsus Pharmaceuticals

Acquirer

Financial adviser
Legal adviser
Target
Alkeus Pharmaceuticals
Acquirer
Tarsus Pharmaceuticals
Target based in
United States
Buyer based in
United States
Sector
Biotech
Tags
Biotech, Ophthalmology, Drug Development

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.